Leap Therapeutics is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.
May 11, 2018Leap Therapeutics Reports First Quarter 2018 Financial Results
April 16, 2018Leap Therapeutics Presents Nonclinical and Clinical Data on DKN-01 at AACR 2018 Annual Meeting
March 27, 2018Leap Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
There are currently no events scheduled.
as of 4:00 PM ETMay 25, 2018
Data provided by Nasdaq. Minimum 15 minutes delayed.